YN001-004 in Patients With Coronary Atherosclerosis in Australia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Teresa Chen, PhD
Beijing Inno Medicine Co., Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Canberra Hospital
Canberra, Australian Capital Territory, Australia
Recruiting - Albury Wodonga Private Hospital
Albury, New South Wales, Australia
Recruiting - Sunshine Coast University Private Hospital
Birtinya, Queensland, Australia
Recruiting - Core Research Group Pty Ltd
Milton, Queesland, Australia
Withdrawn - Altona Clinical Research
Melbourne, Victoria, Australia
Recruiting - Peninsula Heart Centre
Melbourne, Victoria, Australia
Recruiting - John Flynn Private Hospital
Tugun, Australia
Not, yet, recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2026
- Primary completion
- 30 Jun 2026
- Completion
- 30 Jun 2026
- Last update posted
- 17 Feb 2026
- Registered enrollment
- 24
- Registry id
- NCT06700720
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.